Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas A Gallardo, E Lerma, D Escuin, A Tibau, J Munoz, B Ojeda, A Barnadas, ... British journal of cancer 106 (8), 1367-1373, 2012 | 279 | 2012 |
Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas A Gallardo, E Lerma, D Escuin, A Tibau, J Munoz, B Ojeda, A Barnadas, ... British journal of cancer 106 (8), 1367-1373, 2012 | 279 | 2012 |
Over-expression of vascular endothelial growth factor in pituitary adenomas is associated with extrasellar growth and recurrence R Sánchez-Ortiga, L Sánchez-Tejada, O Moreno-Perez, P Riesgo, ... Pituitary 16, 370-377, 2013 | 65 | 2013 |
Increased insulin-like growth factor-1 receptor mRNA expression predicts poor survival in immunophenotypes of early breast carcinoma G Peiro, E Adrover, L Sánchez-Tejada, E Lerma, M Planelles, ... Modern Pathology 24 (2), 201-208, 2011 | 49 | 2011 |
DNA methylation of tumor suppressor genes in pituitary neuroendocrine tumors A García-Martínez, J Sottile, L Sánchez-Tejada, C Fajardo, R Cámara, ... The Journal of Clinical Endocrinology & Metabolism 104 (4), 1272-1282, 2019 | 32 | 2019 |
Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary … L Sánchez-Tejada, R Sánchez-Ortiga, Ó Moreno-Pérez, CF Montañana, ... Endocrinología y Nutrición 60 (7), 358-367, 2013 | 30 | 2013 |
Contribution of molecular analysis to the typification of the non-functioning pituitary adenomas L Sanchez-Tejada, R Sanchez-Ortiga, C Lamas, R Camara, P Riesgo, ... PLoS One 12 (7), e0180039, 2017 | 23 | 2017 |
Low activation of Insulin-like Growth Factor 1-Receptor (IGF1R) is associated with local recurrence in early breast carcinoma G Peiró, S Benlloch, L Sánchez-Tejada, E Adrover, E Lerma, FM Peiró, ... Breast cancer research and treatment 117, 433-441, 2009 | 23 | 2009 |
The Molecular Registry of Pituitary Adenomas (REMAH): A bet by Spanish Endocrinology for the future of individualized medicine and translational research RM Luque, A Ibáñez-Costa, L Sánchez-Tejada, E Rivero-Cortés, ... Endocrinología y Nutrición (English Edition) 63 (6), 274-284, 2016 | 18 | 2016 |
El Registro Molecular de Adenomas Hipofisarios (REMAH): una apuesta de futuro de la Endocrinología española por la medicina individualizada y la investigación traslacional RM Luque, A Ibáñez-Costa, L Sánchez-Tejada, E Rivero-Cortés, ... Endocrinología y Nutrición 63 (6), 274-284, 2016 | 15 | 2016 |
Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment G Peiró, FM Peiró, F Ortiz-Martínez, M Planelles, L Sánchez-Tejada, ... Human pathology 44 (2), 218-225, 2013 | 15 | 2013 |
Rol of pituitary tumour-transforming gene (PTTG) in the pituitary adenomas R Sánchez-Ortiga, O Moreno-Pérez, AL FI Endocrinologia y Nutricion: Organo de la Sociedad Espanola de Endocrinologia …, 2010 | 11 | 2010 |
Severe sleep apnea–hypopnea syndrome is related to left ventricle dysfunction and hypertrophy in acromegalic patients R Sanchez-Ortiga, V Climent, L Sanchez-Tejada, A Candela, A Pico Endocrinología y Nutrición 62 (8), 366-372, 2015 | 9 | 2015 |
Notch and Jak/STAT signaling pathways in breast carcinoma of luminal and basal/triple-negative immunophenotypes. E Adrover, L Sanchez-Tejada, G Peiro, D Giner, E Lerma, FI Aranda, ... Journal of Clinical Oncology 28 (15_suppl), 618-618, 2010 | 1 | 2010 |
Avances en biología molecular en patología neuroendocrina JP Castaño, RM Luque, AL Cerro, M Robledo, LS Tejada Endocrinología y Nutrición 57 (Supl. 1), 2-6, 2010 | 1 | 2010 |
PTEN loss of expression is not related with PTEN promoter hypermethylation in HER2-positive breast carcinoma D Giner, L Sanchez-Tejada, FJ Gutierrez-Avino, L Perez-Carbonell, ... LABORATORY INVESTIGATION 90, 47A-47A, 2010 | 1 | 2010 |
Papel de pituitary tumour-transforming gene (PTTG) en los adenomas hipofisarios R Sánchez-Ortiga, LS Tejada, GP Cabrera, O Moreno-Pérez, ... Endocrinología y nutrición 57 (1), 28-34, 2010 | 1 | 2010 |
Alteraciones moleculares de la señalización estrogénica en el Cáncer de Mama con receptores hormonales positivos L Sánchez Tejada Universidad de Alicante, 2016 | | 2016 |
MiR-7 has a role in behaviour of somatotroph adenomas R Sanchez-Ortiga, L Sanchez-Tejada, C Lamas, R Camara, J Abarca, ... Endocrine Abstracts 37, 2015 | | 2015 |
Role of miR-375 in oncogenesis of pituitary adenomas L Sanchez-Tejada, R Sanchez-Ortiga, P Riesgo, J Abarca, C Fajardo, ... Endocrine Abstracts 37, 2015 | | 2015 |